Category: Lillly
-
New Alzheimer’s drug treatment from Eli Lillly wins FDA approval
•
Eli Lilly & Co. has won U.S. approval for an Alzheimer’s treatment, the second drug to slow the progression of the brain-robbing disease that affects 6 million Americans. It’s a huge win for Lilly and its investors, who have been eagerly awaiting the drug since it hit the market. show…